Form 4 Tracker
Steven H Collis

Director · 6 filings · Latest: May 26, 2026

Bausch & Lomb Corp
Elevance Health, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ELV
Steven H CollisDirectorMar 5, 2026
Purchase
$289.843,000$869.5K3,639
BLCO
Steven H CollisDirectorFeb 23, 2026
Purchase
$17.8115,000$267.1K20,255
COR
COLLIS STEVEN H—Nov 18, 2025
Proposed Sale
$366.6431,349$11.5M—
COR
COLLIS STEVEN H—Nov 6, 2025
Proposed Sale
$355.2550,000$17.8M—
COR
COLLIS STEVEN H—Oct 21, 2025
Proposed Sale
$326.9931,350$10.3M—
COR
COLLIS STEVEN H—Sep 16, 2025
Proposed Sale
$291.5531,350$9.1M—
COR
COLLIS STEVEN H—Aug 19, 2025
Proposed Sale
$289.9814,579$4.2M—
COR
COLLIS STEVEN H—Jul 22, 2025
Proposed Sale
$292.6714,578$4.3M—
COR
COLLIS STEVEN H—Jun 24, 2025
Proposed Sale
$292.6214,579$4.3M—
COR
COLLIS STEVEN H—May 20, 2025
Proposed Sale
$293.8414,578$4.3M—
COR
COLLIS STEVEN H—Apr 22, 2025
Proposed Sale
$281.8114,579$4.1M—
COR
COLLIS STEVEN H—Mar 25, 2025
Proposed Sale
$269.5114,578$3.9M—
COR
COLLIS STEVEN H—Feb 27, 2025
Proposed Sale
$251.0814,579$3.7M—
COR
COLLIS STEVEN H—Nov 25, 2024
Proposed Sale
$243.9850,000$12.2M—
COR
COLLIS STEVEN H—Nov 19, 2024
Proposed Sale
$242.1621,509$5.2M—
COR
COLLIS STEVEN H—Oct 22, 2024
Proposed Sale
$235.8021,509$5.1M—
COR
COLLIS STEVEN H—Sep 17, 2024
Proposed Sale
$241.0121,509$5.2M—